Major retailer offering more than £80 off pizza oven that will be perfect for garden parties
A MAJOR retailer currently has a huge deal on a pizza oven that would be perfect for summer garden parties.
The Range is selling the Westinghouse 12 Inch Pizza Oven for £145, but it's usually on sale for £229 - meaning shoppers can get a massive £80 off.
1
The electric pizza oven can be used both indoors and outdoors and has a 12-inch pizza stone.
A description on The Range's website says the oven can make "homemade authentic pizzas at home in minutes".
As the oven is electric, you won't need anything extra - just the pizza itself.
"All you need to do is plug it in, pre-heat, and your pizza oven is ready to go," it says.
The oven is advertised as easy to clean as it will burn any food residue that's been left over while it's pre-heating.
It is a whopping £155 cheaper than the similar Ninja version, while is selling for £299.99.
However the Ninja Artisan Electric Outdoor Pizza Oven & Air Fryer also has air fryer functions, meaning you could cook things like chicken breasts and chips inside too.
Ninja says the oven can cook pizzas in three minutes or less, with settings including Artisan, Thin Crust, New York and Pan.
Remember, it's always worth shopping around for deals to make sure you get the best price.
For example, The Range's website has pizza ovens at a variety of price points - but you can also check at other shops too.
If you wanted a cheaper option, The Range sells the Pizza Oven Charcoal Grilling for £89.99 (down from £99.99).
The portable wood-fired oven is said to be "perfect for pizzas, roasts, baking and searing".
Unlike the electric pizza oven, you would need a natural firelighter and either kiln-dried hardwood or pizza oven pellets.
The Range says the oven can "cook anything in less than five minutes" as it heats up to 500C.
How to save money on pizza
TAKEAWAY pizzas taste great but they can hit you hard on your wallet. Here are some tips on how to save on pizza:
Cashback websites - TopCashback and Quidco will pay you to order your pizza through them. They're paid by retailers for every click that comes to their website from the cashback site, which eventually trickles down to you. So you'll get cashback on orders placed through them.
Discount codes - Check sites like VoucherCodes for any discount codes you can use to get money off your order.
Make you own topping - One savvy customer noticed that Domino's charges up to 70p MORE for pizzas on its menu compared to ordering the same one through the "create your own" option. It's worth trying out to see if it makes a difference before you place your next order.
Buy it from the shops - It might not taste exactly the same but you'll save the most money by picking up your favourite pizza from your local supermarket. Some Asda stores sell freshly made ones from the pizza counter where prices start at £2.
If you're looking for a pizza oven that can also be used as a BBQ (and you're willing to splash out more), you could try the Outdoor Pizza Oven and Cover by KuKoo.
It comes in at £224.99 but is multi-purpose so you can use it for your BBQ and smoking needs too.
The product description says it's great for baking bread, barbecuing meat and fish, and also works as a smoker for things like pulled pork joints.
How to compare prices to get the best deal
JUST because something is on offer, or is part of a sale, it doesn't mean it's always a good deal.
There are plenty of comparison websites out there that'll check prices for you - so don't be left paying more than you have to.
Most of them work by comparing the prices across hundreds of retailers.
Here are some that we recommend:
Google Shopping is a tool that lets users search for and compare prices for products across the web. Simply type in keywords, or a product number, to bring up search results.
Price Spy logs the history of how much something costs from over 3,000 different retailers, including Argos, Amazon, eBay and the supermarkets. Once you select an individual product you can quickly compare which stores have the best price and which have it in stock.
Idealo is another website that lets you compare prices between retailers. All shoppers need to do is search for the item they need and the website will rank them from the cheapest to the most expensive one.
CamelCamelCamel only works on goods being sold on Amazon. To use it, type in the URL of the product you want to check the price of.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Mamdani says we shouldn't have billionaires after Trump branded him ‘communist lunatic'
New York Democrat Zohran Mamdani, who looks all but certain to be his party's nominee in the city's mayoral race, has said there should be no billionaires. Mamdani made the comments after Donald Trump - himself a billionaire - tore into the mayoral hopeful and branded him a 'communist'. Speaking on NBC's Meet the Press on Sunday morning, Mamdani told host Kristen Welker: 'I don't think that we should have billionaires because, frankly, it is so much money in a moment of such inequality, and ultimately, what we need more of is equality across our city and across our state and across our country. 'And I look forward to working with everyone, including billionaires, to make a city that is fair for all of them.' Mamdani, a state assemblyman who considers himself a democratic socialist, pulled off a major upset in the city's Democratic mayoral primary last Tuesday when he beat front-runner Andrew Cuomo, a victory set to be confirmed when vote counting resumes this week. The progressive ran on a platform of making New York City a more affordable place to live and has pledged to increase taxes for its wealthiest residents to pay for outreach programs. 'Ultimately, the reason I want to increase these taxes on the top one percent, the most profitable corporations, is to increase quality of life for everyone, including those who are going to be taxed,' he told Welker. 'We're seeing that our vision to tax the top one percent of New Yorkers – these are New Yorkers who make a million dollars a year or more – and our proposal is to just tax them by two percent additional, is something that has broad support, and we'll continue to increase that support over the next few months.' Mamdani's win has since seen panicked conservatives race to attack him, with the president launching his own salvo on Friday. Trump predicted that New York would become 'a communistic city' if Mamdani is elected mayor in November and added: 'I can't believe that's happening. That's a terrible thing for our country, by the way.' Earlier in the week, Trump had written on Truth Social: 'Zohran Mamdani, a 100% Communist Lunatic, has just won the Dem Primary, and is on his way to becoming Mayor. We've had Radical Lefties before, but this is getting a little ridiculous.' Asked whether he was a communist by Welker on Sunday, Mamdani answered simply: 'I am not.' Just before that interview aired on NBC, a sit down between Trump and Maria Baritromo had run on Fox News in which the president said of Mamdani: 'Let's say this: If he does get in, I'm going to be president, and he's going to have to do the right thing or they're not getting any money, he's got to do the right thing.' Responding on NBC, the mayoral candidate said: 'I have already had to start to get used to, get used to the fact that the president will talk about how I look, how I sound, where I'm from, who I am, ultimately, because he wants to distract from what I'm fighting for, and I'm fighting for the very working people that he ran a campaign to empower, that he has since then betrayed.' Assuming Mamdani secures the Democratic nomination, he and Adams are likely to find themselves in a three-horse race with Republican Curtis Sliwa, founder of the Guardian Angels anti-crime group. However, Cuomo has signalled that he could also run again, like Adams, as an independent.
The Guardian
3 hours ago
- The Guardian
Wall Street shivers over ‘hot commie summer' after Mamdani's success
When Zohran Mamdani, a 33-year-old self-described socialist, won New York's mayoral Democratic nomination last week over a seasoned but scandal-scarred veteran, the city's financial elite had a meltdown. This was the start of 'hot commie summer' in the city, New York hedgevfund billionaire Daniel Loeb posted to X. John Catsimatidis, billionaire CEO of grocery chain Gristedes and friend of Donald Trump, warned on Fox Business: 'If the city of New York is going socialist, I will definitely close, or sell, or move.' CNBC financial news channel anchor Joe Kernen compared New York to Batman's crime-riddled Gotham. ' They're taking Wall Streeters and making them walk out onto the ice in the East River, And, and then they fall through. I mean there is a class warfare that's going on.' With five months until the mayoral election proper, the 1% are revolting, led by loquacious billionaire hedge funder Bill Ackman, who said he and others in the finance industry are ready to commit 'hundreds of millions of dollars' into an opposing campaign. 'The risk/reward of running for mayor over the next 132 days is extremely compelling as the cost in time and energy is small and the upside is enormous.' Ackman said he was 'gravely concerned' because he believed the leftwing candidate's policies would trigger an exodus of the wealth that would destroy the tax base and undermine New York's public services. The city under Mamdani, he posted on Wedneday, 'is about to become much more dangerous and economically unviable.' In 2021, the top 1% of New York City taxpayers paid 48% of taxes – up from 40% in 2019, according to a report from the city's finance department. But at the same time, New York has become an increasingly unaffordable city for those outside the 1% – especially for people of color. In a post a day later, Ackman said: 'The ability for New York City to offer services for the poor and needy, let alone the average New Yorker, is entirely dependent on New York City being a business-friendly environment and a place where wealthy residents are willing to spend 183 days and assume the associated tax burden. Unfortunately, both have already started making arrangements for the exits.' 'Terror is the feeling,' Kathryn Wylde, the chief executive of the Partnership for New York City, which represents top business leaders, told CNBC on Tuesday. Gerard Filitti, senior legal counsel at the Lawfare Project, a pro-Israel thinktank, non-profit and litigation fund, and a New Yorker with strong ties to the finance industry, said Mamdani's nomination 'marked a dangerous turning point for the city'. 'There's big concern that businesses and the economy will be hurt. There's already a move by business leaders and entrepreneurs to consider a move outside of the city, taking jobs and tax dollars with them, at time when the front-running candidate promises to make even more change that could destroy the economy,' Filitti said. The anger was not necessarily purely economic. Wall Street's decision makers have been shaken after seeing their preferred candidate, Andrew Cuomo, pushed aside despite the millions they poured into his campaign. Fix the City, Cuomo's political action committee (Pac), raised a record $25m to help see off Mamdani. Former New York mayor Michael Bloomberg alone gave $8.3m to the Pac. 'These are billionaires who are giving hundreds of thousands and millions of dollars to Andrew Cuomo precisely because they know we are going to tax them to make life a little bit more affordable here, in the most expensive city in the United States,' Mamdani told the New York Times before the election. 'They know they can count on Cuomo because Cuomo has a track record of rewarding the political donors.' New York's moneyed class argues it's not about them but the future of the city. 'When you look at what New York City is and has been historically – a bastion of trading and the center of world capitalism, the engine of economic growth and prosperity, the stock market, an the inspiration for other world economies to develop their markets and economies in line with New York – and now what were seeing is an economy and quality of life that is slowly deteriorating,' said Filitti. 'Now we have a front-running Democrat candidate who is promising even more radical change and that change is a threat to the structure of New York and the way people identify with New York City,' Filitti added. It's an argument the rich have made many times before. Many of the 1% threatened to leave after former mayor Bill de Blasio called for raising their taxes to pay for the losses the city experienced after the Covid pandemic. Wall Street poured millions into mayor Eric Adam's 2021 campaign for office to see off more progressive candidates. They won those fights; this time, they lost. A former Wall Street CEO told Politico: 'These titans of Wall Street and titans of finance are used to getting their way. They didn't get their way. They got the opposite of their way. They got a guy who couldn't be more disliked by them – and vice versa.' Wall Street's vision for the city is probably far from that shared by many other residents of a sprawling metropolis that traditionally has played host to vibrant immigrant communities from all over the world, many of them poor. It is of course, host to the Statue of Liberty on whose base is written the famous lines: 'Give me your tired, your poor, Your huddled masses yearning to breathe free.' Manhattan was also the birthplace of the Occupy Wall Street protests in the US back in 2011, which occupied the downtown Zucotti Square – blocks from Wall Street – and eventually saw protests spread across the rest of the country and the world. Democratic progressives were quick to celebrate Mamdani's victory. 'Your dedication to an affordable, welcoming, and safe New York City where working families can have a shot has inspired people across the city. Billionaires and lobbyists poured millions against you and our public finance system. And you won,' wrote representative Alexandria Ocasio-Cortez, another progressive who won out against a more establishment candidate. Another longtime critic of Wall Street and the billionaire class also saw a change in politics as usual. 'The American people are beginning to stand up and fight back. We have seen that in the many Fighting Oligarchy events that we've done around the country that have drawn huge turnouts. We have seen that in the millions of people who came out for the No Kings rallies that took place this month in almost every state. And yesterday, we saw that in the Democratic primary in New York City,' senator Bernie Sanders wrote in The Guardian. Millions will now be spent attacking Mamdani. But he has seen off one well-funded attempt to derail his campaign. Whether or not his campaign has the momentum to last until November, remains to be seen. But Wall Streeters have been put on notice that New York, and the changing nature of the Democratic party, may no longer be as amenable to their interests, or their vision for New York.
Telegraph
4 hours ago
- Telegraph
This firm represents one of investing's toughest moral debates
While many big drug companies do amazing things for humanity, they're also often vilified for profiteering from their work. This month, New York-listed Gilead Sciences has, not for the first time, reminded investors of the conundrum. On June 18, Gilead announced it had gained approval from the US regulator for a treatment that some view as having the potential to end the global 'HIV epidemic'. At the same time, it has drawn criticism in anticipation of US prices being set at more than $28,000 (£20,400) per patient, per year. Lenacapavir, to be marketed by Gilead under the name Yeztugo, is a twice-yearly injection that prevents people from contracting HIV. This has the potential to disrupt the market for preventative HIV drugs, which is currently dominated by another Gilead treatment, a daily pill named Descovy. Financially, Gilead hopes to gain from lenacapavir by expanding the market for preventative HIV treatments. It also could benefit from existing users of Descovy switching to the somewhat more expensive new treatment, and people switching from other long-lasting preventatives such as GSK's bi-monthly Apretude. The breakthrough is important in strengthening Gilead's HIV franchise more broadly, too. HIV drugs accounted for almost 70pc of product sales last year, and year-on-year growth of HIV-related revenues came in at 8pc in the first quarter. The group's single biggest-selling drug is Biktarvy, a treatment for people who are already HIV positive. The daily oral pill generates around $13.4bn of sales, or 47pc of the group total. Gilead is currently leveraging its research into lenacapavir by attempting to develop a twice-yearly treatment in this space, too. Gilead's major drug breakthroughs have not always proved as rewarding for shareholders as they have for patients. Covid-19 sent the shares on a roller-coaster ride after one of Gilead's hepatitis C treatments, called Remdesivir, was originally found to also be very effective against the coronavirus. Sales of the drug, rebranded Veklury, hit $5.6bn in 2021 but rapidly fell as the pandemic eased, and revenues are expected to be just $1.3bn this year. An earlier breakthrough in the treatment of hepatitis C in the 2010s, meanwhile, caused huge share price excitement, with revenues ballooning to nearly $14bn in 2015 before the drug became a victim of its own success. Because the drug, called Harvoni, found a way to cure the disease as opposed to managing it, it did away with much of its own market. Rising competition also contributed to a rapid decline in sales. However, many top investors are more bullish on the lenacapavir breakthrough. Financial publisher Citywire, which tracks where the world's best fund managers are investing, has found 12 backing the shares – all among the best-performing 3pc of equity managers globally. The level of these bets puts Gilead among the 74 stocks that make up Citywire's Global Elite Companies index, which represents the very best ideas from the roughly 6,000 stocks held across the portfolios of top fund managers. Optimism about Gilead's prospects can be seen in its share price, too. The valuation against forecast earnings is within the top 5pc of the 10-year range. While in some circumstances this would be grounds to worry about the shares being expensive, the fact Gilead is only valued at 13 times forecast earnings makes it is more a reason to take heart than worry. Indeed, the uninspiring valuations of previous years reflect the ups and downs associated with Veklury and Harvoni. Today, the future looks much brighter. Sales of Veklury appear to be stabilising and now represent a relatively small proportion of the business. Meanwhile, as well as the strong HIV franchise, the company is experiencing solid growth in cancer and liver disease treatments. The drug development pipeline also looks strong, and is supported by about a fifth of sales going into research and development (R&D) each year. The group also does not face any major loss of patents until 2033. Meanwhile, attempts to drive down operating costs are benefiting the bottom line. The good progress has been reflected in analysts raising their earnings forecasts over the last 12 months. Expectations for the current year and next are both up by more than 10pc over the period, and while there is some downward pressure on revenue from US drug pricing policies, Gilead looks relatively well placed due to its focus on novel medicines. Its extensive US operations also reduce the threat from tariffs. The shares offer an attractive 3pc forecast dividend yield, and the company has a strong track record for returning cash. British buyers of the shares, which are available through all the big broking platforms, need to fill out the current paperwork to minimise withholding tax and should also check for any extra dealing charges. While walking the tightrope between profit and purpose is never easy, as an investment, Gilead looks better placed than it has for quite some time. Questor says buy Ticker: NYSE:GILD
